Dec 15 (Reuters) - Klaria Pharma Holding AB KLAR.ST :
* SAID ON TUESDAY HAS BOUGHT OUT REMAINING PURCHASE PRICE
THAT WAS
AGREED BETWEEN PARTIES IN CONNECTION WITH KLARIA ACQUIRING
UPPSALAGRUPPEN MEDICAL AB FROM FFT MEDICAL
* REMAINING PURCHASE PRICE CONSISTED OF RIGHT TO BOTH
LICENSE
INCOME AND ROYALTY PAYMENTS, BASED ON PATENT HELD BY
UPPSALAGRUPPEN
* KLARIA AND FFT MEDICAL HAVE NOW SETTLED PURCHASE PRICE
THROUGH
ONE-TIME PAYMENT
Source text for Eikon: urn:newsml:reuters.com:*:nWkr5ZmBYZ
Further company coverage: KLAR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))